Jeffrey David Lebensburger DO MSPH
Professor, Pediatrics, University of Alabama at Birmingham School of Medicine
Join to View Full Profile
1600 7th Ave SBirmingham, AL 35233
Phone+1 205-939-5423
Dr. Lebensburger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr Lebensburger is a board certified Pediatric Hematologist Oncologist. He specializes in Hematology with national expertise in SCD Nephropathy
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of Florida (Orlando)Residency, Pediatrics, 2003 - 2006
Nova Southeastern University College of Osteopathic MedicineClass of 2003
Certifications & Licensure
AL State License 2009 - 2025
WI State License 2014 - 2014
TN State License 2006 - 2009
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Scholar Award American Society of Hematology
- Best Doctors in America Best Doctors
Clinical Trials
- Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease Start of enrollment: 2012 Aug 16
- Preventing Sickle Cell Kidney Disease Start of enrollment: 2015 Apr 01
- Acute Kidney Injury in Patients With Sickle Cell Disease Start of enrollment: 2017 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia.Rima S Zahr, Guolian Kang, Xu Zhang, Sara R Rashkin, Csaba P Kovesdy
American Journal of Hematology. 2025-04-05 - 1 citationsMulticenter comparative study of polysomnography outcomes in children with the monogenic disorder sickle cell disease.Ammar Saadoon Alishlash, Anis Rabbani Nourani, Jeffrey Lebensburger, Jennifer A Rothman, Tarig Ali-Dinar
Journal of Clinical Sleep Medicine. 2025-02-01 - Biomarkers to Differentiate Acute Chest Syndrome From Vaso-Occlusive Crisis in Children With Sickle Cell Disease.Karen Wang, Nelida Olave, Saurabh Aggarwal, Joo-Yeun Oh, Rakesh P Patel
European Journal of Haematology. 2025-02-01
Authored Content
- Outcomes in Mild to Moderate Isolated ThrombocytopeniaJuly 2018
Press Mentions
More Multidisciplinary Care May Help Close Significant Disparity in SCD TreatmentJanuary 31st, 2025- Priapism in Sickle Cell Disease: Associations Between NOS3 and EDN1 Genetic Polymorphisms and Laboratory BiomarkersFebruary 4th, 2021
- Marijuana Use and Health Behaviors in a US Clinic Sample of Patients with Sickle Cell DiseaseJuly 14th, 2020
- Join now to see all
Grant Support
- Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell AnemiaUNIVERSITY OF ALABAMA AT BIRMINGHAM2020–2025
- Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell AnemiaUNIVERSITY OF ALABAMA AT BIRMINGHAM2020–2025
- Chronobiology and Chronopharmacology to Prevent Sickle NephropathyNational Heart Lung Blood Institute2015–2019
- Scholar AwardAmerican Society of Hematology2015–2018
- Sickle Cell Aspire GrantPfizerPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
